Vyant Bio (VYNT) Short Interest Ratio & Short Volume

Short interest is the volume of Vyant Bio shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 42,600 shares of VYNT short. Learn More on Vyant Bio's current short interest.

Vyant Bio saw a drop in short interest in December. As of December 31st, there was short interest totaling 42,600 shares, a drop of 2.3% from the previous total of 43,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Vyant Bio: Aclarion, Inc. (0.95%), Invitae Co. (26.15%), Comera Life Sciences Holdings, Inc. (2.38%), Remedent, Inc. (0.00%), TC Biopharm (Holdings) Plc (35.10%), SQZ Biotechnologies (0.09%), Virax Biolabs Group Limited (0.69%), GlobeStar Therapeutics Co. (0.01%), Sunshine Biopharma, Inc. (7.32%), Biodexa Pharmaceuticals Plc (14.70%),

As of the most recent reporting period, the following stocks had the largest short interest positions: General Motors ($4.15 billion), T-Mobile US, Inc. ($3.92 billion), TC Energy Co. ($3.66 billion), Charter Communications, Inc. ($3.35 billion), Coinbase Global, Inc. ($3.32 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.80 billion), Rivian Automotive, Inc. ($2.44 billion), Moderna, Inc. ($2.41 billion), and United Rentals, Inc. ($2.23 billion). View all of the most shorted stocks.

Short selling VYNT is an investing strategy that aims to generate trading profit from Vyant Bio as its price is falling. VYNT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Vyant Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VYNT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VYNT, twice per month. The most recent reporting period available is December, 31 2023.